Market Access & Pricing Strategy

• Develop and execute tailored market access strategies for rare disease and ATMP portfolios across Saudi Arabia, UAE, Kuwait, and broader GCC markets.
• Lead payer engagement with key bodies including SFDA/NHIC, DHA, HAAD, MOH Kuwait, and relevant HTA committees, adapting value frameworks to local evidence requirements.
• Build health economic and outcomes research (HEOR) arguments and dossiers to support reimbursement and funding decisions, including outcomes-based and managed entry agreement models where applicable.
• Navigate the unique access landscape for high-cost therapies, one-time treatments, and CGTs — including budget impact models, registries, and patient support programme design.
• Monitor evolving reimbursement policies, HTA developments, and national rare disease frameworks to proactively adapt access strategies.

Product Launch & Commercial Execution

• Lead integrated launch planning and execution for new rare disease and ATMP assets entering the region, coordinating cross-functional workstreams including regulatory, medical, supply, and patient access.
• Establish launch readiness frameworks, KPIs, and go-to-market timelines in close alignment with biotech partners.
• Drive commercial performance through forecasting, account management, and key account engagement with treating centres, multidisciplinary teams, and patient advocacy groups.
• Drive innovative solutions that enable optimal market access strategies for ATMP assets, particularly in settings with complex reimbursement pathways and unclear patient journeys.
• Ensure compliant, patient-centric access pathways are in place prior to and following commercial launch, including named patient, compassionate use, and early access programmes.
• Manage and strengthen Uniphar’s network of local distributors and 3rd party vendors across GCC markets, while driving expansion strategies into additional countries within the MENA region.

Business Development & Asset Evaluation

• Identify, evaluate, and prioritise new asset and partnership opportunities within the rare disease and ATMP space for the MENA region.
• Conduct structured opportunity assessments and due diligence reviews, including market sizing, patient population mapping, competitive landscape analysis, pricing benchmarking, and revenue modelling.
• Develop and present investment cases to senior leadership to support partnership decision-making and resource allocation.
• Build and maintain a network of biotech and pharma partners, advisors, and ecosystem stakeholders to support deal sourcing and pipeline development.

Regulatory & Operational Coordination

• Support regulatory submission strategies and liaison with local regulatory authorities as part of launch readiness, working with regulatory affairs resources internally and at partner companies.
• Oversee patient support programme design, special access pathways, and supply chain considerations for rare disease products requiring specialised handling or distribution.
• Ensure compliance with all local legal, promotional, and pharmacovigilance requirements across the portfolio.

Essential

• 10+ years of pharmaceutical or biotech industry experience, with a strong grounding across at least two of the following disciplines: market access, and commercial/launch management.
• Demonstrated experience in rare disease and/or ATMP / CGT commercialisation — including deep familiarity with the patient journey, small patient populations, and the access complexities unique to these categories.
• Hands-on experience in the GCC or broader MENA region, with working knowledge of key payer, regulatory, and HTA stakeholders across Saudi Arabia, UAE, and Kuwait.
• Proven track record of leading or materially contributing to successful product launches in the region.
• Experience with business development or asset evaluation, including the ability to conduct independent opportunity assessments and communicate findings to senior stakeholders.
• Ability to operate effectively across medical, access, and commercial functions — comfortable navigating ambiguity and prioritising across competing demands.

Preferred

• Advanced degree in life sciences, pharmacy, or medicine (MD, PharmD, PhD or equivalent); an MBA or business qualification is a plus.
• Experience working with or within a speciality distributor, regional commercial partner, or similar partnership-driven commercial model.
• Existing relationships with rare disease KOLs, patient advocacy organisations, or payer stakeholders in the GCC.
• Familiarity with health economic modelling tools and reimbursement dossier development for high-cost therapies.
• Proficiency in Arabic; strong written and spoken English is essential.